Bioactive Compounds from Marine Actinobacteria

Marine actinobacteria signify a revolutionary frontier in the natural product discovery field by producing numerous secondary metabolites with unique therapeutic capabilities. Marine actinobacteria have been isolated from extreme marine environments and have evolved biosynthetic pathways that allow them to create different compounds. As terrestrial sources of natural products are exhausting and multidrug resistance is a major concern, marine actinobacteria represent a new and largely untapped chemical resource. Prominent classes of bioactive compounds produced by marine actinobacteria include polyketides, non-ribosomal peptides, alkaloids, and terpenes. Polyketides tend to have complex structures, such as salinosporamide A, a polyketide that has progressed to Phase I trials for cancer. Non-ribosomal peptides show significant antimicrobial and immunosuppressive potential (for example, a potent antibiotic, which is a non-ribosomal peptide (NRP). Alkaloids usually have broad-spectrum antibacterial properties. Terpenes also demonstrate anticancer, anti-inflammatory, and antiviral properties. In addition to antimicrobial applications, bioactive compounds produced by marine actinobacteria have also been developed by pharmaceutical companies for cancer therapy. The advancement of genomic mining, OSMAC methods, and co-cultivation has accelerated the discovery rate of natural products produced by actinobacteria. Marine actinobacteria are also contributing to the fields of biotechnology, biofuels, food processing, and bioremediation. Thus, marine actinobacteria are nature’s chemists, adapted over millions of years to extreme environments and yield an extensive collections of bioactive molecules that will ultimately change the face of drug discovery and biotechnology.